Company intelligence / Profile preview

Alexander

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Alexander Pharmaceuticals is a biotechnology company focused on developing innovative treatments for central nervous system (CNS) disorders. The company utilizes its proprietary A-DRIVE platform to optimize the delivery and efficacy of small molecule therapeutics, aiming to overcome traditional barriers in brain-targeted drug delivery. Their current research efforts are primarily directed toward addressing unmet needs in schizophrenia and Parkinson's disease. By leveraging advanced formulation technologies, Alexander Pharmaceuticals seeks to improve patient outcomes through enhanced bioavailability and reduced side effects.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeDrug delivery system
Industry: Biotech

Beyond the preview

Go deeper on Alexander.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alexander.

Explore the full profile